Response to influenza vaccine in people with non-protective HI antibody titers
Author(s) -
Vincenzo Baldo,
Tatjana Baldovin,
Annarosa Floreani,
Michele Minuzzo,
R. Trivello
Publication year - 2006
Publication title -
european journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.825
H-Index - 111
eISSN - 1573-7284
pISSN - 0393-2990
DOI - 10.1007/s10654-006-9071-4
Subject(s) - medicine , immunogenicity , vaccination , immunization , influenza vaccine , virology , immunology , titer , antibody titer , antibody response , antibody , virus , immune system
The purpose of the study was to determine which factors correlate directly with response to vaccination in such a group of subjects with non-protective HI antibody titers before vaccination. Two vaccines were used, a subunit virus vaccine adjuvanted with MF59 and a split virus vaccine. The analysis indicated that immunization with vaccine adjuvanted with MF59 was an independent variable for immune response against A/H3N2 (OR: 3.51; 95% CI: 1.81-6.79) and B (OR: 2.31; 95% CI: 1.37-3.89). The results suggest that antibody response to vaccine is satisfactory in elderly people previously lacking a protective antibody titer, and that the adjuvanted vaccine reveals a better immunogenicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom